Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration.

Biol Pharm Bull. 1995 Nov;18(11):1566-71. Unique Identifier : AIDSLINE MED/96161468
Ogiso T; Paku T; Iwaki M; Tanino T; Faculty of Pharmaceutical Sciences, Kinki University, Osaka,; Japan.


Abstract: To identify the mechanism involved in the enhancement effect of enhancers on the intercellular penetration of large polar molecules, the skin penetration of fluorescein isothiocyanate (FITC)-dextrans (average molecular weight; 4400, 9400, and 69000 Da) and the lipid removal from the intercellular spaces by enhancers were studied using hairless rat skin. Pretreatment of hairless rat skin with enhancers such as n-octanol (20%), laurocapram (2%), isopropylmyristate (IPM, 20%), oleic acid (5%) and cineol (2%), which are water-immiscible, significantly enhanced the flux of FITC-dextrans, while pretreatment with water-miscible enhancers, i.e. dimethyl sulfoxide (DMSO, 5%) and N-methyl-2-pyrrolidone (NMP) did not increase the flux compared with the control. The penetration of FITC-dextrans was approximately size dependent. n-Octanol, laurocapram, IPM and oleic acid dramatically removed ceramides which are the intercellular lipids, whereas NMP and DMSO partly extracted the sphingolipids. A linear relationship was observed between the flux and removal of ceramides (p < 0.01), indicating that the removal of intercellular lipids would cause dramatic dilations between adherent cornified cells and enhance the penetration through the intercellular pathways. When the penetration of FITC-dextrans through Wistar rat skin was compared with that via hairless rat skin, the steady state flux of FITC-dextrans through Wistar rat skin pretreated with water-immiscible enhancers was 1.2- to 4.9-fold higher, suggesting that the penetration of large polar molecules through follicles may play at least some role in the percutaneous absorption.
Keywords: Alcohol, Ethyl/PHARMACOLOGY Animal Azepines/PHARMACOLOGY Ceramides/CHEMISTRY Dextrans/*PHARMACOKINETICS Epidermis/CHEMISTRY/METABOLISM Fluorescein-5-isothiocyanate/*ANALOGS & DERIVATIVES/ PHARMACOKINETICS In Vitro Lipids/CHEMISTRY Male Menthol/ANALOGS & DERIVATIVES/PHARMACOLOGY Myristates/PHARMACOLOGY Oleic Acids/PHARMACOLOGY Pharmaceutic Aids/*PHARMACOLOGY Rats Rats, Wistar Skin/CHEMISTRY Skin Absorption/*DRUG EFFECTS Sphingolipids/CHEMISTRY JOURNAL ARTICLE

KWDalcohol,ethyl/pharmacologyanimalazepines/pharmacologyceramides/chemistrydextrans/KWDpharmacokineticsepidermis/chemistry/metabolismfluorescein-5-isothiocyanate/KWDanalogs&derivatives/pharmacokineticsinvitrolipids/chemistrymalementhol/analogs&derivatives/pharmacologymyristates/pharmacologyoleicacids/pharmacologypharmaceuticaids/KWDpharmacologyratsrats,wistarskin/chemistryskinabsorption/KWDdrugeffectssphingolipids/chemistryjournalarticle
960630
M9660718


Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .